Generation and Utilization of a Monoclonal Antibody against Hepatitis B Virus Core Protein for a Comprehensive Interactome Analysis.

Hepatitis B virus antibody-based in situ biotinylation hypoxia interactome analysis monoclonal antibody

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
30 Nov 2022
Historique:
received: 10 10 2022
revised: 22 11 2022
accepted: 29 11 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 24 12 2022
Statut: epublish

Résumé

Hepatitis B virus (HBV) core antigen (HBc) is a structural protein that forms the viral nucleocapsid and is involved in various steps of the viral replication cycle, but its role in the pathogenesis of HBV infection is still elusive. In this study, we generated a mouse monoclonal antibody (mAb) against HBc and used it in antibody-based in situ biotinylation analysis in order to identify host proteins that interact with HBc. HBc antigen was produced with a wheat germ cell-free protein synthesis system and used to immunize mice. Among the established hybridoma clones, a single clone (mAb #7) was selected and further characterized for its ability in the antibody-based in situ biotinylation analysis to collect host proteins that are in the vicinity of HBc. Using mass spectrometry, we identified 215 HBc-interacting host proteins, three of which bind HBc most significantly under hypoxic conditions. Our results indicate that mAb #7 can be used to systematically identify host proteins that interact with HBc under pathophysiological conditions, and thus may be useful to explore the molecular pathways involved in HBV-induced cytopathogenesis.

Identifiants

pubmed: 36557634
pii: microorganisms10122381
doi: 10.3390/microorganisms10122381
pmc: PMC9783060
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Japan Agency for Medical Research and Development
ID : JP21fk0310103
Organisme : Japan Agency for Medical Research and Development
ID : JP22fk0310507

Références

Front Microbiol. 2016 Apr 20;7:509
pubmed: 27148198
FASEB J. 2018 Jun;32(6):3033-3046
pubmed: 29401603
PLoS One. 2009 Oct 08;4(10):e7388
pubmed: 19812689
Front Immunol. 2021 Apr 21;12:590679
pubmed: 33968009
Nat Commun. 2022 May 25;13(1):2905
pubmed: 35614107
Sci Rep. 2020 Aug 24;10(1):14101
pubmed: 32839523
Biochem Biophys Res Commun. 2014 Sep 26;452(3):315-21
pubmed: 25150444
J Pharmacol Exp Ther. 2013 Jul;346(1):48-53
pubmed: 23620539
PLoS Pathog. 2018 Mar 2;14(3):e1006937
pubmed: 29499066
World J Gastroenterol. 2014 May 14;20(18):5427-34
pubmed: 24833873
Front Microbiol. 2021 Sep 16;12:724877
pubmed: 34603251
Front Pharmacol. 2022 Jul 18;13:895608
pubmed: 35924040
Int J Mol Sci. 2021 Dec 20;22(24):
pubmed: 34948447
Cell. 2018 Dec 13;175(7):1931-1945.e18
pubmed: 30550790
Viruses. 2020 Mar 05;12(3):
pubmed: 32151000
Cold Spring Harb Perspect Med. 2015 May 01;5(5):a021436
pubmed: 25934462
J Virol. 1995 Oct;69(10):6158-69
pubmed: 7666518
Anal Chim Acta. 2008 Oct 3;627(1):71-81
pubmed: 18790129
Front Microbiol. 2014 May 13;5:208
pubmed: 24860558
J Virol. 2007 Feb;81(4):1641-9
pubmed: 17135319
Cell Death Differ. 2009 Feb;16(2):219-29
pubmed: 18927587
Proteomics. 2012 May;12(10):1576-90
pubmed: 22611051
J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S343-S351
pubmed: 34590138
J Hepatol. 2022 Apr;76(4):975-980
pubmed: 34990751
J Biol Chem. 2011 Jul 8;286(27):23645-51
pubmed: 21566121
J Hepatol. 2016 Apr;64(1 Suppl):S49-S59
pubmed: 27084037
Antiviral Res. 2018 Jan;149:211-220
pubmed: 29183719
Hepatology. 2021 Oct;74(4):1766-1781
pubmed: 33991110
Biochem Biophys Res Commun. 2020 Jun 18;527(1):64-70
pubmed: 32446392
Nat Biotechnol. 2020 Jun;38(6):675-678
pubmed: 32444850
J Hepatol. 2021 Jul;75(1):64-73
pubmed: 33516779
J Clin Med. 2021 Mar 02;10(5):
pubmed: 33801181
PLoS One. 2017 Oct 24;12(10):e0186982
pubmed: 29065155
Int J Mol Sci. 2016 Sep 06;17(9):
pubmed: 27608012
PLoS Pathog. 2020 Nov 12;16(11):e1008593
pubmed: 33180834
Nucleic Acids Res. 2013 Jan;41(Database issue):D566-70
pubmed: 23125365
PLoS Pathog. 2010 Oct 28;6(10):e1001162
pubmed: 21060813
Curr Protoc Protein Sci. 2018 Feb 21;91:19.23.1-19.23.15
pubmed: 29516480
Clin Cancer Res. 2018 Jan 15;24(2):474-485
pubmed: 29084919
Viruses. 2020 Jul 08;12(7):
pubmed: 32650547
Nat Protoc. 2007;2(8):1896-906
pubmed: 17703201
Sci Rep. 2021 Jan 13;11(1):944
pubmed: 33441627
Cell Microbiol. 2021 Feb;23(2):e13274
pubmed: 33006186
Eur J Biochem. 2003 Feb;270(4):570-8
pubmed: 12581197
Sci Rep. 2017 Jan 23;7:41089
pubmed: 28112229
Nat Methods. 2018 Feb;15(2):127-133
pubmed: 29256494
Biochem Biophys Res Commun. 2014 Jan 17;443(3):808-13
pubmed: 24342612
J Cell Biol. 2012 Mar 19;196(6):801-10
pubmed: 22412018
Hepatology. 2006 Oct;44(4):915-24
pubmed: 17006908
Clin Infect Dis. 2002 Dec 1;35(11):1368-75
pubmed: 12439800
Brief Bioinform. 2019 Jul 19;20(4):1160-1166
pubmed: 28968734
Cells. 2021 Jul 13;10(7):
pubmed: 34359934
Epigenetics. 2011 Jun;6(6):720-6
pubmed: 21546797
Sci Rep. 2017 Sep 6;7(1):10620
pubmed: 28878350

Auteurs

Yusuke Nakai (Y)

Department of Microbiology, Yokohama City University School of Medicine, Yokohama 236-0004, Japan.
Advanced Medical Research Center, Yokohama City University, Yokohama 236-0004, Japan.

Kei Miyakawa (K)

Department of Microbiology, Yokohama City University School of Medicine, Yokohama 236-0004, Japan.

Yutaro Yamaoka (Y)

Department of Microbiology, Yokohama City University School of Medicine, Yokohama 236-0004, Japan.
Life Science Laboratory, Technology and Development Division, Kanto Chemical Co., Inc., Isehara 259-1146, Japan.

Yasuyoshi Hatayama (Y)

Department of Microbiology, Yokohama City University School of Medicine, Yokohama 236-0004, Japan.
Advanced Medical Research Center, Yokohama City University, Yokohama 236-0004, Japan.

Mayuko Nishi (M)

Department of Microbiology, Yokohama City University School of Medicine, Yokohama 236-0004, Japan.

Hidefumi Suzuki (H)

Department of Molecular Biology, Yokohama City University School of Medicine, Yokohama 236-0004, Japan.

Hirokazu Kimura (H)

Department of Health Science, Gunma Paz University Graduate School, Takasaki 370-0006, Japan.

Hidehisa Takahashi (H)

Department of Molecular Biology, Yokohama City University School of Medicine, Yokohama 236-0004, Japan.

Yayoi Kimura (Y)

Advanced Medical Research Center, Yokohama City University, Yokohama 236-0004, Japan.

Akihide Ryo (A)

Department of Microbiology, Yokohama City University School of Medicine, Yokohama 236-0004, Japan.
Advanced Medical Research Center, Yokohama City University, Yokohama 236-0004, Japan.

Classifications MeSH